- Home
- PSTV vs LSBPW Comparison
PSTV vs LSBPW Comparison
Compare PSTV & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- LSBPW
- Stock Information
- Founded
- PSTV 1996
- LSBPW N/A
- Country
- PSTV United States
- LSBPW China
- Employees
- PSTV N/A
- LSBPW 758
- Industry
- PSTV Medical/Dental Instruments
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- PSTV Health Care
- LSBPW Health Care
- Exchange
- PSTV Nasdaq
- LSBPW Nasdaq
- Market Cap
- PSTV 9.4M
- LSBPW N/A
- IPO Year
- PSTV N/A
- LSBPW N/A
- Fundamental
- Price
- PSTV $1.41
- LSBPW $0.07
- Analyst Decision
- PSTV Strong Buy
- LSBPW
- Analyst Count
- PSTV 2
- LSBPW 0
- Target Price
- PSTV $14.00
- LSBPW N/A
- AVG Volume (30 Days)
- PSTV 84.6K
- LSBPW N/A
- Earning Date
- PSTV 10-29-2024
- LSBPW N/A
- Dividend Yield
- PSTV N/A
- LSBPW N/A
- EPS Growth
- PSTV N/A
- LSBPW N/A
- EPS
- PSTV N/A
- LSBPW N/A
- Revenue
- PSTV $5,509,000.00
- LSBPW N/A
- Revenue This Year
- PSTV $11.13
- LSBPW N/A
- Revenue Next Year
- PSTV N/A
- LSBPW N/A
- P/E Ratio
- PSTV N/A
- LSBPW N/A
- Revenue Growth
- PSTV 113.20
- LSBPW N/A
- 52 Week Low
- PSTV $0.97
- LSBPW N/A
- 52 Week High
- PSTV $2.78
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- PSTV 46.79
- LSBPW N/A
- Support Level
- PSTV $1.20
- LSBPW N/A
- Resistance Level
- PSTV $1.45
- LSBPW N/A
- Average True Range (ATR)
- PSTV 0.10
- LSBPW 0.00
- MACD
- PSTV 0.01
- LSBPW 0.00
- Stochastic Oscillator
- PSTV 57.37
- LSBPW 0.00
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.